北京当升材料科技股份有限公司 关于董事辞职的公告 证券代码：300073 证券简称：当升科技 公告编号：2025-035 北京当升材料科技股份有限公司 关于董事辞职的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 北京当升材料科技股份有限公司（以下称"公司"）董事会于 2025 年 4 月 18 日收到董事肖林兴先生的书面辞职报告。肖林兴先生因个人原因申请辞去公 司第六届董事会董事及董事会审计委员会委员职务。辞职后，肖林兴先生不再担 任公司任何职务。 根据《公司法》和《公司章程》的相关规定，肖林兴先生的辞职未导致公司 董事会人数低于法定最低人数要求，不会影响公司董事会正常运作，其辞职报告 自送达公司董事会之日起生效。公司将尽快按照法定程序补选董事。 截至本公告披露日，肖林兴先生未持有本公司股份，亦不存在应当履行而未 履行的承诺事项。 肖林兴先生在担任公司董事期间，恪尽职守，勤勉尽责。公司董事会对肖林 兴先生在任职期间为公司发展做出的贡献表示衷心感谢！ 特此公告。 北京当升材料科技股份有限公司董事会 2025 年 4 月 18 日 1 ...

中信证券股份有限公司 关于北京当升材料科技股份有限公司 2024年度跟踪报告 | 保荐人名称：中信证券股份有限公司 | 被保荐公司简称：当升科技 | | --- | --- | | 保荐代表人姓名：刘拓 | 联系电话：010-60838913 | | 保荐代表人姓名：李雨修 | 联系电话：010-60836975 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1.公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 无 | | 2．督导公司建立健全并有效执行规章制度的情况 | | | （1）是否督导公司建立健全规章制度（包括但不 | | | 限于防止关联方占用公司资源的制度、募集资金 | 是 | | 管理制度、内控制度、内部审计制度、关联交易 | | | 制度） | | | | 是，根据当升科技《2024年度内部控制评价报 | | （2）公司是否有效执行相关规章制度 | 告》《2024年度内部控制审计报告》，公司有 | | | 效执行了相关规章制度。 | | 3.募集资金监督情况 | | | （1） ...

中信证券股份有限公司 | 11.从事风险投资、委托理财、套期保值业务等事项是否建 | 是 | | --- | --- | | 立了完备、合规的内控制度 | | | （三）信息披露 | | 现场检查手段： 查阅上市公司信息披露文件，投资者关系登记表，深圳证券交易所互动易网站披 露信息，重大信息的传递披露流程文件，内幕信息管理和知情人登记管理情况， 信息披露管理制度，会计师出具的内部控制审计报告，检索公司舆情报道，对高 级管理人员进行访谈。 关于北京当升材料科技股份有限公司 2024 年度持续督导定期现场检查报告 | 保荐人名称：中信证券股份有限公司 被保荐公司简称：当升科技 | | | | | --- | --- | --- | --- | | （以下简称"中信证券"或"保荐人"） | | | | | 保荐代表人姓名：刘拓 联系电话：010-60838913 | | | | | 保荐代表人姓名：李雨修 联系电话：010-60836975 | | | | | 现场检查人员姓名：刘拓、索超、刘冠宏、屈晨曦、李志强、李昊 | | | | | 现场检查对应期间：2024 1 日至 2024 年 12 月 31 日 | ...

Group 1: Company Performance and Market Impact - The company experienced a decline in performance in Q4 2024 due to factors such as slower growth in the overseas electric vehicle industry, intensified competition, and a decrease in international customer sales proportion [2] - Despite the challenges, the company maintains a leading position in overall operational performance and profitability within the industry [4] - The company’s business volume in the U.S. market is relatively small, thus not significantly affected by the recent U.S. tariff policies [20] Group 2: Future Growth and Strategic Initiatives - The company is optimistic about future growth, focusing on multi-element cathode materials, lithium iron phosphate, and solid-state battery materials, with long-term supply agreements signed with international clients like LG and SK [7][11] - The company plans to enhance production capacity for lithium iron phosphate to meet strong downstream demand, with ongoing construction of the Panzhihua production base [9] - The solid-state battery materials have seen significant growth, with nearly 1,000 tons shipped in 2024, indicating a multi-fold increase year-on-year [5] Group 3: International Expansion and Project Development - The company is advancing its European new materials industry base project, which has received environmental permits from the Finnish government, aiming to meet local supply needs for international clients [8][16] - The project is expected to enter the construction phase in 2025, with a focus on establishing high-end production capacity to support global electric vehicle markets [8][16] Group 4: Financial Management and Investor Relations - The company emphasizes the importance of market value management and plans to enhance operational quality and governance to stabilize stock prices [19] - The company has implemented various measures to protect the interests of investors, particularly small shareholders, and aims to boost investor confidence [3][6]

Investment Rating - The report maintains a rating of "Buy" for the company [1][5] Core Views - The company's performance is under pressure due to market competition and the bankruptcy of Northvolt, but the acceleration of new lithium battery materials' marketization is expected to improve future performance [3][8] - The company reported a net profit of 472 million RMB for 2024, a decrease of 75.48% year-on-year, with total revenue of 7.593 billion RMB, down 49.80% year-on-year [8][9] Financial Summary - The company’s revenue is projected to recover from 7.593 billion RMB in 2024 to 10.159 billion RMB in 2025, reflecting a growth rate of 33.8% [7] - The adjusted earnings per share (EPS) forecasts for 2025, 2026, and 2027 are 1.35 RMB, 1.68 RMB, and 2.06 RMB respectively, with corresponding price-to-earnings ratios of 27.0, 21.6, and 17.6 [5][10] - The company’s EBITDA is expected to increase from 571 million RMB in 2024 to 993 million RMB in 2025 [7][10] Market Performance - The company's stock has underperformed, with a year-to-date absolute return of -6.4% and a 12-month return of -30.5% [2] - The total market capitalization of the company is approximately 18.45 billion RMB [2]

-广告- 关注公众号，点击公众号主页右上角" ··· "，设置星标 "⭐" ，关注 鑫椤锂电 资讯~ 本文来源：当升科技 3月30日，由北京市科委、中关村管委会举办的中关村国际技术交易大会成功召开，发布《百项新技术新 产品榜单》。 当升科技"固态电池专用双相复合超高镍正极材料"项目成功入选，体现了公司在新能源材 料领域的技术领先优势。 随着新能源汽车市场的不断扩大和消费者对高性能电池需求的日益增长，固态电池等新一代电池加速发 展。正极材料作为电池的关键材料在其中发挥着至关重要的作用。 当升科技开发了具有自主知识产权的固 态电池专用双相复合超高镍正极材料。 该正极材料采用超稳定快离子导体修饰技术，解决了固态电解质与正极材料界面阻抗大、副反应严重等瓶 颈难题；采用新一代双相复合工艺，解决了超高镍正极材料安全性差、产气严重等实用化问题。该产品具 有 安全性好、能量密度高、循环寿命长、高低温存储性能优等特点， 综合性能处于国际水平，获得多家 先进固态电池企业的广泛认可和批量订单，应用于电动汽车、无人机、电动垂直起降飞行器（EVTOL）等 高安全、长续航锂电池领域，具有广阔的市场前景。 进固态电池群 ，加小编微信：13 ...

报告要点 [Table_Summary] 公司发布 2024 年年报，实现营业收入 75.9 亿元，同比-49.8%，实现归母净利润 4.7 亿元，同 比-75.48%，实现扣非净利润 2.7 亿元，同比-86.23%；拆至 2024Q4，公司实现营业收入 20.7 亿元，同比下降 19.96%，归母净利润 0.1 亿元，同比下降 98.26%，环比下降 95.75%，实现 扣非净利润-0.5 亿元，同比下降 114.26%，环比下降 146.56%。 分析师及联系人 [Table_Author] 丨证券研究报告丨 公司研究丨点评报告丨当升科技（300073.SZ） [Table_Title] 减值计提拖累业绩，看好新技术&海外成长性 邬博华 曹海花 叶之楠 SAC：S0490514040001 SAC：S0490522030001 SAC：S0490520090003 SFC：BQK482 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 当升科技（300073.SZ） cjzqdt11111 公司研究丨点评报告 [Table_Rank]投资评级 买入丨维持 公 ...

其他化学制品Ⅱ 分析师：牟国洪 登记编码：S0730513030002 证券研究报告-年报点评 增持(维持) 市场数据(2025-04-01) | 收盘价(元) | 40.85 | | --- | --- | | 一年内最高/最低(元) | 54.10/27.15 | | 沪深 300 指数 | 3,887.68 | | 市净率(倍) | 1.57 | | 流通市值(亿元) | 206.36 | | 基础数据(2024-12-31) | | | 每股净资产(元) | 26.00 | | 每股经营现金流(元) | 3.15 | | 毛利率(%) | 12.38 | | 净资产收益率_摊薄(%) | 3.58 | | 资产负债率(%) | 20.03 | | 总股本/流通股(万股) | 50,650.08/50,516.07 | | B 股/H 股(万股) | 0.00/0.00 | 个股相对沪深 300 指数表现 -36% -27% -18% -9% 1% 10% 19% 28% 2024.04 2024.08 2024.11 2025.03 当升科技 沪深300 资料来源：中原证券研究所 地址： 上海浦东新区 ...

Investment Rating - The report maintains an "Accumulate" investment rating for the company, indicating a projected increase in stock price relative to the CSI 300 index over the next six months [1][11]. Core Views - The company's performance is under short-term pressure, with a significant decline in revenue and profits for 2024, but there are expectations for recovery in 2025 driven by increasing demand for lithium battery materials [5][6][8]. - The report highlights the growth in China's new energy vehicle sales and battery production, which is expected to boost the demand for cathode materials [6][8]. - The company has established long-term supply agreements with major clients, which are anticipated to positively impact future performance [9][11]. Summary by Sections Financial Performance - In 2024, the company reported revenue of 7.593 billion yuan, a decrease of 49.80% year-on-year, with a net profit of 472 million yuan, down 75.48% [6][12]. - The operating cash flow increased by 30.74% to 1.598 billion yuan, indicating improved cash generation despite declining profits [6]. - The company plans to distribute a cash dividend of 2.0 yuan per 10 shares [6]. Market Trends - In 2024, China's new energy vehicle sales reached 12.859 million units, a year-on-year increase of 36.10%, contributing to a growing demand for cathode materials [6][8]. - The production of power batteries in China grew by 40.96% in 2024, with expectations for continued growth in 2025 [6][8]. Product and Capacity Development - The company achieved a sales volume of 10.07 million tons of lithium battery materials in 2024, a significant increase of 60.53% year-on-year [8]. - The company is expanding its production capacity, with a total capacity of 129,000 tons by the end of 2024, and plans to add 80,000 tons of high-end capacity in 2025 [8][9]. Strategic Partnerships - The company has signed long-term supply agreements with SK On and LGES, which are expected to secure significant sales volumes and enhance market position [9][11]. - A strategic cooperation framework was established with Zhongwei Co., focusing on resource development and product supply [9]. Future Outlook - The company anticipates a recovery in performance in 2025, driven by increasing demand for lithium battery materials and stabilization of raw material prices [8][9]. - The projected earnings per share for 2025 and 2026 are 1.34 yuan and 1.85 yuan, respectively, with corresponding price-to-earnings ratios of 30.45 and 22.04 [11][12].

Macro Strategy - The March PMI data indicates three characteristics of economic recovery: the pre-positioning of work due to the Spring Festival, better recovery of manufacturing demand compared to supply, and weak consumer service consumption [1][30]. - The manufacturing PMI for March is 50.5%, showing a slight increase of 0.3 percentage points from the previous month, while the service PMI is at 50.3%, also up by 0.3 percentage points [1][30]. - The new order index for manufacturing increased by 0.7 points to 51.8%, indicating stronger demand recovery compared to supply [1][30]. Industry Insights - The report highlights the need for macro policies to be adjusted in response to potential economic pressures in the second quarter, particularly in exports and real estate [1][30]. - The construction industry PMI rose to 53.4%, reflecting seasonal recovery, but remains at a historically low level for this time of year [1][30]. - The report emphasizes the importance of monitoring the impact of tariff increases on exports and the ongoing trends in the real estate market [1][30]. Company Analysis - The report provides insights into various companies, including their performance forecasts and investment ratings, such as the significant growth in sales for Lao Pu Gold and the strategic partnerships for Jianghuai Automobile [9][15]. - Companies like Yubiquitous and Geli Pharmaceutical are noted for their innovative product developments and market potential, with investment ratings maintained at "buy" [11][12]. - Shanghai Pharmaceuticals reported a revenue of 275.25 billion yuan, reflecting a 5.75% year-on-year increase, with a net profit of 4.553 billion yuan, up 20.82% [14]. Financial Performance - The report indicates that the overall financial performance of companies is under scrutiny, with adjustments made to profit forecasts for several firms based on market conditions and operational challenges [15][19]. - Companies such as China Communications Construction Company and Orient Securities are highlighted for their revenue growth and strategic adjustments in response to market dynamics [22][23]. - The report also notes the importance of cash flow management and cost control in maintaining profitability amid fluctuating market conditions [22][24].